Cargando…
Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279117/ http://dx.doi.org/10.1097/MD.0000000000006039 |
Ejemplares similares
-
Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study
por: Wei, Ping, et al.
Publicado: (2016) -
The Role of Macrolides in Noncystic Fibrosis Bronchiectasis
por: Figueiredo, Bruna de Campos Guimarães e, et al.
Publicado: (2011) -
Noncystic fibrosis bronchiectasis: Is it an orphan disease?
por: Mobaireek, Khalid F.
Publicado: (2007) -
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis
por: Bonaiti, Giulia, et al.
Publicado: (2015) -
Retraction Notice
Publicado: (2011)